Literature DB >> 11571501

Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs.

S D Rowley1.   

Abstract

Transplantation between red cell-disparate donor and recipient is feasible with minimal increase in the risk of transplantation if consideration is given to the immunohematological consequences of the transplant. The risks of immediate and delayed hemolysis must be managed. Some recipients will experience a delay in the recovery of red blood cells.

Entities:  

Mesh：

Year:  2001        PMID： 11571501     DOI： 10.1038/sj.bmt.1703135

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  20 in total

1.  Antibodies to biotinylated red blood cells in adults and infants: improved detection, partial characterization, and dependence on red blood cell-biotin dose.

Authors:  Robert L Schmidt; Donald M Mock; Robert S Franco; Robert M Cohen; Anne K North; José A Cancelas; Christof Geisen; Ronald G Strauss; Alexander P Vlaar; Demet Nalbant; John A Widness
Journal:  Transfusion       Date:  2017-03-05       Impact factor: 3.157

Review 2.  The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when.

Authors:  Nicola Daniele; Maria Cristina Scerpa; Cecilia Rossi; Alessandro Lanti; Gaspare Adorno; Giancarlo Isacchi; Francesco Zinno
Journal:  Blood Transfus       Date:  2013-11-21       Impact factor: 3.443

3.  Immune-mediated cytopenia in pediatric primary immune deficiency patients following HSCT.

Authors:  J H Chewning; I Aban; H L Haines; R Brown; H H Buchanan; F D Goldman
Journal:  Bone Marrow Transplant       Date:  2017-08-07       Impact factor: 5.483

4.  Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.

Authors:  Matthew R Kudek; Ryan Shanley; Nicole D Zantek; David H McKenna; Angela R Smith; Weston P Miller
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-02       Impact factor: 5.742

5.  Essential requirements for setting up a stem cell processing laboratory.

Authors:  T Leemhuis; D Padley; C Keever-Taylor; D Niederwieser; T Teshima; F Lanza; C Chabannon; P Szabolcs; A Bazarbachi; M B C Koh
Journal:  Bone Marrow Transplant       Date:  2014-06-16       Impact factor: 5.483

Review 6.  Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes.

Authors:  Joan Cid; Miguel Lozano; Harvey G Klein; Willy A Flegel
Journal:  Blood Transfus       Date:  2014-03-19       Impact factor: 3.443

Review 7.  Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.

Authors:  Patricia M Kopko
Journal:  Transfus Med Hemother       Date:  2015-10-29       Impact factor: 3.747

8.  Major ABO incompatible BMT in children: determining what residual volume of donor red cells can safely be infused following red cell depletion.

Authors:  K Patrick; W Lau; A Gassas; E McDougall; J Doyle; M Ali; J Krueger; S Courtney; C Armstrong; R M Egeler; T Schechter
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

9.  Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.

Authors:  Gordana Tomac; Ines Bojanić; Sanja Mazić; Ivana Vidović; Mirela Raos; Branka Golubić Ćepulić; Ranka Serventi Seiwerth; Jadranka Kelečić; Boris Labar
Journal:  Blood Transfus       Date:  2017-04-19       Impact factor: 3.443

Review 10.  ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Nina Worel
Journal:  Transfus Med Hemother       Date:  2015-10-29       Impact factor: 3.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.